Post-doctoral Researcher
University at Buffalo, School of Pharmacy & Pharmaceutical Sciences
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
My main research focus has been on clinical pharmacology and clinical-translational pharmacometric approaches as it relates to antibiotics and he treatment of extensively resistant and pan resistant bacteria. My current projects are looking into novel dosing schemes used in the treatment of resistant gram negative 'superbugs;' developing model-based approaches to optimize treatment regimens; and using population studies in tandem with my wet-bench research to better understand what these new therapies mean for patient treatment. As a clinician-scientist, my objectives are to design, test, then implement patient- and bacteria-specific treatments in order to optimize patient outcomes.
